Blumhouse Atomic Reports $1.3 Billion Year
The merged horror studio generated over 2.5 billion dollars in total revenue against low production costs since its 2024 formation.
By Mei Lin ·

The combined horror production entity known as Blumhouse Atomic has generated 1.3 billion dollars in worldwide box office revenue so far in 2026. This figure comes from two specific titles released by the company this year. The financial results demonstrate the high return on investment associated with the studio's low-budget strategy.
James Wan and Jason Blum officially named the new umbrella organization on November 3, 2026. The merger of their two companies, Blumhouse and Atomic Monster, took place in 2024. Despite the unification under the Blumhouse Atomic banner, the original brands will continue to operate as separate production labels. Creative teams will continue to develop and produce film and television projects under their respective historical names.
Since the 2024 union, the combined banners have generated more than 2.5 billion dollars in global box office revenue. Their combined production budgets for these releases totaled less than 330 million dollars. This financial efficiency is a core component of the company's business model. The leadership team stated that the new structure provides the output capacity of a major studio while maintaining the creative freedom and financial discipline typical of an independent company.
Blum described the rebranding as a natural progression of their long collaborative history. He noted that the union has proven the whole is greater than the sum of its parts. The portfolio now includes major franchises such as The Conjuring, Insidious, and Saw. Blum pointed to the development of a new Saw chapter as an example of the partnership's synergy, noting that the franchise has returned to Wan's direction.
The 2026 revenue was driven primarily by two major hits. Obsession, directed by Curry Barker, earned 520 million dollars worldwide. Backrooms, directed by Kane Parsons, grossed 400 million dollars globally. These successes have solidified the company's market position and validated the strategy of backing established directors with new material.
Wan emphasized the importance of discovering new voices in the horror genre. He expressed a commitment to supporting filmmakers who started with small projects and were given the chance to prove themselves. Wan cited his work with directors Kane Parsons, Curry Barker, Josh Giuliano, and Dylan Clark as key examples of this approach. The goal is to provide these filmmakers with the freedom to create distinctive work and to build lasting professional relationships that extend beyond single films.
To support its mission of creating blockbuster horror from smaller budgets, the company made several strategic hires. Sam Zimmerman was appointed as senior vice president of development and acquisitions. His role involves developing a slate of genre features, with a specific focus on projects that have budgets under 5 million dollars. The company also signed a first-look deal with Divide/Conquer to develop high-concept projects at an economical rate.
Blumhouse Atomic has announced a substantial film slate for 2027. The upcoming lineup includes established franchises and new concepts. The list features River, The Revenge of La Llorona, The Exorcist: Martyrs, and Anything But Ghosts. It also includes entries from popular series such as Paranormal Activity, Blair Witch, and Molepeople, alongside new projects like Sleepover and Seasons.
The strategic expansion reflects the company's intent to take these stories beyond traditional theatrical releases. Blum mentioned that there are now more opportunities to adapt these properties into television, video games, and live experiences. The rebranding marks a milestone in the careers of both Wan and Blum as they continue to define the modern horror market.
More Business · National news · Customer Complaints · Report a business · Got a Story?






